Ace Inhibitors Current Events | Ace Inhibitors News | 11
|
| Page
11 of
19 |
379 Results |
|
|
|
Sort By:
Page Views | Date |
Penn study suggests a new type of pain reliever that may benefit the heart
Building on previous work, researchers at the University of Pennsylvania School of Medicine have found that deleting an inflammation enzyme in a mouse model of heart disease slowed the development of atherosclerosis. view more (2006-09-13)
ESC Congress 2004: First EuroAction Results Demonstrate Need For Implementation of Guidelines to Improve Cardiovascular Disease Prevention
Largest Study In Preventive Cardiology Aims to Improve Patient Outcomes view more (2004-08-31)
U-M researchers discover gene switched off in cancer can be turned on
A gene implicated in the development of cancer cells can be switched on using drugs, report researchers from the University of Michigan Comprehensive Cancer Center. view more (2007-06-12)
Researchers provide dose of education to lower blood pressure
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has launched a $3.7 million, three-year educational effort to improve high blood pressure control nationwide. view more (2006-02-03)
Experimental drug shows promise against head and neck cancer
A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck. The work is reported in the April 28th online edition of the Journal of Pathology. view more (2009-04-29)
Anthrax inhibitor counteracts toxin, may lead to new therapeutics
Researchers from Rensselaer Polytechnic Institute and the University of Toronto have designed a nanoscale assembly of molecules that successfully counteracts and inhibits anthrax toxin in animal and laboratory experiments. view more (2006-04-24)
Genetic analysis of glioblastoma brain tumors can aid in treatment decisions, study shows
Screening glioblastoma brain tumors for two gene variations can reliably predict which tumors will respond to a specific class of drugs, a new study shows. view more (2005-11-10)
Studies to date say erectile dysfunction drugs affect other systems, mostly for the better
Since the Food and Drug Administration gave Viagra® (sildenafil) its approval in 1998, "erectile dysfunction" has become a household term — probably to the chagrin of many parents fielding questions from their kids watching TV. view more (2006-06-16)
Depressed dialysis patients more likely to be hospitalized or die, researcher finds
Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found. view more (2008-09-15)
Depressed dialysis patients more likely to be hospitalized or die, researcher finds
Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found. view more (2008-09-17)
How stem cells are regulated
Researchers from Biotech Research & Innovation Centre (BRIC) at University of Copenhagen have identified a new group of proteins that regulate the function of stem cells. The results are published in the new issue of Cell. view more (2007-02-23)
Aspirin might prevent Vioxx cardiac damage
Low-dose aspirin might prevent the cardiovascular damage known to arise from use of the painkiller rofecoxib (Vioxx®), suggest new findings from mouse studies by Duke University Medical Center researchers. view more (2005-09-14)
New evidence shows MabThera inhibits joint damage in patients with rheumatoid arthritis
New data presented at the EULAR meeting (European League Against Rheumatism) show for the first time that MabThera (rituximab), a unique B cell targeted therapy, is able to significantly inhibit structural damage of joints caused by rheumatoid arthritis (RA). view more (2006-06-22)
Urine test may help monitor disfiguring birthmarks
Vascular anomalies - birthmarks caused by abnormal development of arteries, capillaries, veins or lymph vessels - can sometimes begin to progress, requiring aggressive treatment to save the child's health or vision. view more (2005-07-06)
PAPER OF THE YEAR 2004 (p 2166)
THE LANCET Paper of the Year 2004 has been won by Craig Whittington and colleagues' for their systematic review of selective serotonin-reuptake inhibitors in childhood depression published in the April 2004 issue. view more (2004-12-15)
Photonic crystal biosensors detect protein-DNA interactions
Scientists at the University of Illinois have developed a new class of disposable, microplate-based optical biosensors capable of detecting protein-DNA interactions. Based on the properties of photonic crystals, the biosensors are suitable for the rapid identification of inhibitors of protein-nucleic acid and protein-protein interactions. view more (2008-09-24)
New study: Pycnogenol reduces heart failure
A study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart. view more (2007-05-17)
Study identifies another strategy for normalizing tumor blood supply
Manipulating levels of nitric oxide (NO), a gas involved in many biological processes, may improve the disorganized network of blood vessels supplying tumors, potentially improving the effectiveness of radiation and chemotherapy. view more (2008-02-21)
Gas-blockers might slow down Alzheimer's disease
A noxious gas speeds up brain degeneration in Alzheimer's disease, according to a study in the November 7 issue of The Journal of Experimental Medicine. view more (2005-10-31)
The UAB heads a European research project on proteases and pathological processes
A research group of the UAB Institute of Biotechnology and Biomedicine and the UAB Department of Biochemistry and Molecular Biology, directed by Francesc Xavier Avilés, is the coordinator of a European project aimed at studying proteases with fluorescent molecules that allow their monitoring in healthy and pathological situations. view more (2007-07-18)
|
|
| Page
11 of
19 |
379 Results |
|
|
|
Sort By:
Page Views | Date |
|
